1. Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin? Özdemir BC, Dotto GP. Trends Cancer. (2017), 3:181-197. doi: 10.1016/j.trecan.2017.02.002.

2 Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast activation. Clocchiatti, A., S. Ghosh, M.G. Procopio, L. Mazzeo, P. Bordignon, P. Ostano, S. Goruppi, G. Bottoni, A. Katarkar, M. Levesque, P. Kölblinger, R. Dummer, V. Neel, B.C. Ozdemir, and G.P. Dotto. J. Clin. Invest. (2018). 128: p. 5531-5548 doi: 10.1172/JCI99159.

3. Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology. Özdemir, B.C., Csajka, C., Dotto, G.P., and Wagner, A.D. (2018). J Clin Oncol, 36, 2680-2683 JCO2018783290.

4. The challenges of modelling hormone receptor-positive breast cancer in mice. Özdemir BC, Sflomos G, Brisken C. (2018) Endocr Relat Cancer.:R319-R330. doi: 10.1530/ERC-18-0063.